Neuroprotection and neuronal dysfunction upon repetitive inhibition of oxidative phosphorylation

Experimental Neurology

Volumn 183, Issue 2, 2003, Pages 346-354

  Hellweg, R ^a   Von Arnim, C A F ^b   Buchner M ^b   Huber, R ^b   Riepe, M W ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Growth factors; Hypoxia; Neurodegeneration; Neuroprotection; Preconditioning

Indexed keywords

3 NITROPROPIONIC ACID; ADENOSINE A1 RECEPTOR; ADENOSINE A3 RECEPTOR; AMYLOID BETA PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; NERVE GROWTH FACTOR; NITRIC OXIDE SYNTHASE; PROTEIN PRECURSOR; SUCCINATE DEHYDROGENASE (UBIQUINONE);

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN FUNCTION; BRAIN HYPOXIA; BRAIN NERVE CELL; CELL ACTIVITY; CONTROLLED STUDY; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HIPPOCAMPUS; IN VIVO STUDY; INJECTION; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 0141449073     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00127-4     Document Type: Article

References (57)

1. Abe K., Tanz R.E., Kogure K. Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci. Lett. 125:1991;172-176.
2. Aketa S., Nakase H., Kamada Y., Hiramatsu K., Sakaki T. Chemical preconditioning with 3-nitropropionic acid in gerbil hippocampal slices therapeutic window and the participation of adenosine receptor . Exp. Neurol. 166:2000;385-391.
3. Almli C.R., Levy T.J., Han B.H., Shah A.R., Gidday J.M., Holtzman D.M. BDNF protects against spatial memory deficits following neonatal hypoxia-ischemia. Exp. Neurol. 166:2000;99-114.
4. Araki W., Wurtman R.J. Increased expression of amyloid precursor protein and amyloid precursor-like protein 2 during trophic factor withdrawal-induced death of neuronal PC12 cells. Brain Res. Mol. Brain Res. 56:1998;169-177.
5. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses. Ann. Neurol. 31:1992;119-130.
6. Beal M.F., Brouillet E., Jenkins B.G., Ferrante R.J., Kowall N.W., Miller J.M., Storey E., Srivastava R., Rosen B.R., Hyman B.T. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13:1993;4181-4192.
7. Behrens M.M., Strasser U., Lobner D., Dugan L.L. Neurotrophin-mediated potentiation of neuronal injury. Microsc. Res. Tech. 45:1999;276-284.
8. Binienda Z., Kim C.S. Increase in levels of total free fatty acids in rat brain regions following 3-nitropropionic acid administration. Neurosci. Lett. 230:1997;199-201.
9. Borlongan C.V., Koutouzis T.K., Freeman T.B., Cahill D.W., Sanberg P.R. Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease. Brain Res. 697:1995;254-257.
10. Bossi S.R., Simpson J.R., Isacson O. Age dependence of striatal neuronal death caused by mitochondrial dysfunction. NeuroReport. 4:1993;73-76.
11. Brouillet E., Jenkins B.G., Hyman B.T., Ferrante R.J., Kowall N.W., Srivastava R., Roy D.S., Rosen B.R., Beal M.F. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J. Neurochem. 60:1993;356-359.
12. Chyi T., Chang C. Temporal evolution of 3-nitropropionic acid-induced neurodegeneration in the rat brain by T2-weighted, diffusion-weighted, and perfusion magnetic resonance imaging. Neuroscience. 92:1999;1035-1041.
13. Coles C.J., Edmondson D.E., Singer T.P. Inactivation of succinate dehydrogenase by 3-nitropropionate. J. Biol. Chem. 254:1979;5161-5167.
14. Feig S., Lipton P. N-Methyl-D-aspartate receptor activation and Ca2+ account for poor pyramidal cell structure in hippocampal slices. J. Neurochem. 55:1990;473-483.
15. Fredholm B.B., Dunwiddie T.V., Bergman B., Lindstrom K. Levels of adenosine and adenine nucleotides in slices of rat hippocampus. Brain Res. 295:1984;127-136.
16. Fukuyama R., Chandrasekaran K., Rapoport S.I. Nerve growth factor-induced neuronal differentiation is accompanied by differential induction and localization of the amyloid precursor protein (APP) in PC12 cells and variant PC12S cells. Brain Res. Mol. Brain Res. 17:1993;17-22.
17. Geddes J.W., Pang Z., Wiley D.H. Hippocampal damage and cytoskeletal disruption resulting from impaired energy metabolism. Implications for Alzheimer disease. Mol. Chem. Neuropathol. 28:1996;65-74.
18. Ghribi O., Lapierre L., Girard M., Ohayon M., Nalbantoglu J., Massicotte G. Hypoxia-induced loss of synaptic transmission is exacerbated in hippocampal slices of transgenic mice expressing C-terminal fragments of Alzheimer amyloid precursor protein. Hippocampus. 9:1999;201-205.
19. Hagberg H., Andersson P., Lacarewicz J., Jacobson I., Butcher S., Sandberg M. Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J. Neurochem. 49:1987;227-231.
20. Hamilton B.F., Gould D.H. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid a type of hypoxic (energy deficient) brain damage . Acta Neuropathol. 72:1987;286-297.
21. Hellweg R., Baethge C., Hartung H.D., Bruckner M.K., Arendt T. NGF level in the rat sciatic nerve is decreased after long-term consumption of ethanol. NeuroReport. 7:1996;777-780.
22. Hellweg R., Gericke C.A., Jendroska K., Hartung H.D., Cervos-Navarro J. NGF content in the cerebral cortex of non-demented patients with amyloid-plaques and in symptomatic Alzheimer's disease. Int. J. Dev. Neurosci. 16:1998;787-794.
23. Hellweg R., Hock C., Hartung H.D. An improved and rapid highly sensitive enzyme immunoassay for nerve growth factor. Technique J. Methods Cell. Mol. Biol. 1:1989;43-48.
24. Hellweg R., Von Richthofen S., Anders D., Baethge C., Ropke S., Hartung H.D., Gericke C.A. The time course of nerve growth factor content in different neuropsychiatric diseases - a unifying hypothesis. J. Neural Transm. 105:1998;871-903.
25. Heurteaux C., Lauritzen I., Widmann C., Lazdunski M. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc. Natl. Acad. Sci. USA. 92:1995;4666-4670.
26. Hock C., Heese K., Hulette C., Rosenberg C., Otten U. Region-specific neurotrophin imbalances in Alzheimer disease decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas . Arch. Neurol. 57:2000;846-851.
27. Kasischke K., Huber R., Li H., Timmler M., Riepe M.W. Primary hypoxic tolerance and chemical preconditioning during estrus cycle in mice. Stroke. 30:1999;1256-1262.
28. Kasischke K., Ludolph A.C., Riepe M.W. NMDA-antagonists reverse increased hypoxic tolerance by preceding chemical hypoxia. Neurosci. Lett. 214:1996;175-178.
29. Kirschner P.B., Jenkins B.G., Schulz J.B., Finkelstein S.P., Matthews R.T., Rosen B.R., Beal M.F. NGF, BDNF and NT-5 but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals. Brain Res. 713:1996;178-185.
30. Kitagawa K., Matsumoto M., Tagaya M., Hata R., Ueda H., Niinobe M., Handa N., Fukunaga R., Kimura K., Mikoshiba K., Kamada T. 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 528:1990;21-24.
31. Lewin G.R., Barde Y.A. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19:1996;289-317.
32. Miller P.J., Zaborszky L. 3-Nitropropionic acid neurotoxicity visualization by silver staining and implications for use as an animal model of Huntington's disease . Exp. Neurol. 146:1997;212-229.
33. Moechars D., Dewachter I., Lorent K., Reverse D., Baekelandt V., Naidu A., Tesseur I., Spittaels K., Haute C.V., Checler F., Godaux E., Cordell B., Van Leuven F. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274:1999;6483-6492.
34. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia a delay of lethal cell injury in ischemic myocardium . Circulation. 74:1986;1124-1136.
35. Nakase H., Heimann A., Uranishi R., Riepe M.W., Kempski O. Early-onset tolerance in rat global cerebral ischemia induced by a mitochondrial inhibitor. Neurosci. Lett. 290:2000;105-108.
36. Perez-Pinzon M.A., Mumford P.L., Rosenthal M., Sick T.J. Anoxic preconditioning in hippocampal slices role of adenosine . Neuroscience. 75:1996;687-694.
37. Popa-Wagner A., Schroder E., Walker L.C., Kessler C. beta-Amyloid precursor protein and ss-amyloid peptide immunoreactivity in the rat brain after middle cerebral artery occlusion effect of age . Stroke. 29:1998;2196-2202.
38. Price D.L., Tanzi R.E., Borchelt D.R., Sisodia S.S. Alzheimer's disease genetic studies and transgenic models . Annu. Rev. Genet. 32:1998;461-493.
39. Rathbone M.P., Middlemiss P.J., Gysbers J.W., Andrew C., Herman M.A., Reed J.K., Ciccarelli R., Di Iorio P.D., Caciagli F. Trophic effects of purines in neurons and glial cells. Prog. Neurobiol. 59:1999;663-690.
40. Riepe M., Hori N., Ludolph A.C., Carpenter D.O., Spencer P.S., Allen C.N. Inhibition of energy metabolism by 3-nitropropionic acid activates ATP-sensitive potassium channels. Brain Res. 586:1992;61-66.
41. Riepe M., Ludolph A., Seelig M., Spencer P.S., Ludolph A.C. Increase of ATP levels by glutamate antagonists is unrelated to neuroprotection. NeuroReport. 5:1994;2130-2132.
42. Riepe M.W., Esclaire F., Kasischke K., Schreiber S., Nakase H., Kempski O., Ludolph A.C., Dirnagl U., Hugon J. Increased hypoxic tolerance by chemical inhibition of oxidative phosphorylation "chemical preconditioning" J. Cereb. Blood Flow Metab. 17:1997;257-264.
43. Riepe M.W., Hori N., Ludolph A.C., Carpenter D.O. Failure of neuronal ion exchange, not potentiated excitation, causes excitotoxicity after inhibition of oxidative phosphorylation. Neuroscience. 64:1995;91-97.
44. Riepe M.W., Kasischke K., Gericke C.A., Lowe A., Hellweg R. Increase of hypoxic tolerance in rat hippocampal slices following 3-nitropropionic acid is not mediated by endogenous nerve growth factor. Neurosci. Lett. 211:1996;9-12.
45. Riepe M.W., Niemi W.N., Megow D., Ludolph A.C., Carpenter D.O. Mitochondrial oxidation in rat hippocampus can be preconditioned by selective chemical inhibition of succinic dehydrogenase. Exp. Neurol. 138:1996;15-21.
46. Schabitz W.R., Sommer C., Zoder W., Kiessling M., Schwaninger M., Schwab S. Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke. 31:2000;2212-2217.
47. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498.
48. Shi J., Yang S.H., Stubley L., Day A.L., Simpkins J.W. Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model. Brain Res. 853:2000;1-4.
49. Siegel G.J., Chauhan N.B. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res. Brain Res. Rev. 33:2000;199-227.
50. Sugino T., Nozaki K., Takagi Y., Hashimoto N. 3-Nitropropionic acid induces ischemic tolerance in gerbil hippocampus in vivo. Neurosci. Lett. 259:1999;9-12.
51. Tomimoto H., Akiguchi I., Wakita H., Nakamura S., Kimura J. Ultrastructural localization of amyloid protein precursor in the normal and postischemic gerbil brain. Brain Res. 672:1995;187-195.
52. Tomimoto H., Wakita H., Akiguchi I., Nakamura S., Kimura J. Temporal profiles of accumulation of amyloid beta/A4 protein precursor in the gerbil after graded ischemic stress. J. Cereb. Blood Flow Metab. 14:1994;565-573.
53. Von Arnim C.A., Timmler M., Ludolph A.C., Riepe M.W. Adenosine receptor up-regulation initiated upon preconditioning but not upheld . NeuroReport. 11:2000;1223-1226.
54. Von Arnim C.A., Timmler M., Ludolph A.C., Riepe M.W. Chemical preconditioning in mice is not mediated by upregulation of nitric oxide synthase isoforms. Neurosci. Lett. 299:2001;130-134.
55. Wallace W.C., Akar C.A., Lyons W.E. Amyloid precursor protein potentiates the neurotrophic activity of NGF. Brain Res. Mol. Brain Res. 52:1997;201-212.
56. Wiegand F., Liao W., Busch C., Castell S., Knapp F., Lindauer U., Megow D., Meisel A., Redetzky A., Ruscher K., Trendelenburg G., Victorov I., Riepe M., Diener H.C., Dirnagl U. Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19:1999;1229-1237.
57. Yun J.K., McCormick T.S., Judware R., Lapetina E.G. Cellular adaptive responses to low oxygen tension apoptosis and resistance . Neurochem. Res. 22:1997;517-521.